| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |